0000899243-20-018256.txt : 20200702
0000899243-20-018256.hdr.sgml : 20200702
20200702160227
ACCESSION NUMBER: 0000899243-20-018256
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HealthCap VII, L.P.
CENTRAL INDEX KEY: 0001645161
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39344
FILM NUMBER: 201009197
BUSINESS ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1000-1018
BUSINESS PHONE: 41 21 614 3500
MAIL ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1000-1018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HealthCap VII GP S.A.
CENTRAL INDEX KEY: 0001790047
STATE OF INCORPORATION: V7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39344
FILM NUMBER: 201009199
BUSINESS ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1006
BUSINESS PHONE: 41-21-614 35 00
MAIL ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1006
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001805890
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
BUSINESS PHONE: 289-799-0891
MAIL ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-30
1
0001805890
Fusion Pharmaceuticals Inc.
FUSN
0001645161
HealthCap VII, L.P.
C/O HEALTHCAP VII GP S.A.,
18 AVENUE OF D'OUCHY
LAUSANNE
V8
CH-1006
SWITZERLAND
0
0
1
0
0001790047
HealthCap VII GP S.A.
C/O HEALTHCAP VII GP S.A.,
18 AVENUE OF D'OUCHY
LAUSANNE
V8
CH-1006
SWITZERLAND
0
0
1
0
Common Shares
2020-06-30
4
C
0
2497345
A
2497345
I
See Footnote
Common Shares
2020-06-30
4
C
0
1069902
A
3567247
I
See Footnote
Common Shares
2020-06-30
4
P
0
240000
17.00
A
3807247
I
See Footnote
Class A Preferred Exchangeable Shares
2020-06-30
4
C
0
13333333
D
Common Shares
2497345
0
I
See Footnote
Class B Preferred Exchangeable Shares
2020-06-30
4
C
0
5712216
D
Common Shares
1069902
0
I
See Footnote
Represents Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemable into Class A Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class A Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis.
The securities are directly held by HealthCap VII, L.P. ("HCLP"). HealthCap VII GP SA ("HCSA") is the sole general partner of HCLP and has voting and investment control over the Shares and Preferred Stock held by HCLP. Johan Christenson has an indirect interest in HCSA and is an employee of HealthCap VII Advisor AB. Each of the General Partner and Dr. Christenson disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that the General Partner or Dr. Christenson is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Represents Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemable into Class B Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class B Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis.
/s/ HealthCap VII L.P., By: By: HealthCap VII GP S.A., its general partner, By: /s/ Dag Richter, Name: Dag Richter, Title: Director, and By: /s/ Fabrice Bernhard, Name: Fabrice Bernhard, Title: General Manager
2020-07-02
/s/ HealthCap VII GP S.A., By: /s/ Dag Richter, Name: Dag Richter, Title: Director, and By: /s/ Fabrice Bernhard, Name: Fabrice Bernhard, Title: General Manager
2020-07-02